
Since 2020, schools in New Zealand have been suspending students who smoke or use e-cigarettes due to the popularity of these habits among young people. As of now, nearly 20,000 students have been suspended.
A report from the New Zealand Ministry of Education states, "Smoking-related illnesses caused work stoppages for 1,210 people in 2020, which increased to 2,865 people in 2021, making up 59% of the total increase in work-related illnesses during the period of 2020-2021.
A report has stated that among the 75% of individuals who have experienced a rise in numbers between 2020 and 2021, smoking or using electronic cigarettes is considered to be at least partially responsible for the increase.
Ben Youdan, Director of the Smoke-Free 2025 campaign, stated that while they do not want young people to smoke or use e-cigarettes, they also do not want schools to suspend students from their studies as a result.
Youdan suggests discussing with students who use tobacco products to explain health risks and help them quit using tobacco products, as well as providing them with smoking cessation support.
A report has revealed that in 2021, 15,968 students in New Zealand schools were suspended a total of 20,980 times. This is an increase of approximately 2,800 over the previous year.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.










